Sanofi’s Tolebrutinib Gets EMA Backing After Failing To Win Over US Regulators

 
• By Vibha Sharma
  
Doctor examining MRI images of patient with multiple sclerosis in clinic, closeup
Disability progression is a critical unmet need in multiple sclerosis (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Product Reviews